condition-management 9 min read

Hepatic Lipidosis (Fatty Liver) in the Obese Cat: A Practical Management Guide

Breed: Obese Cat | Published: July 9, 2026 | Source: allpets.ai

Hepatic lipidosis is a life-threatening fatty liver disease triggered by anorexia in obese cats. Early aggressive nutritional support, especially placement of an esophagostomy tube, and careful monitoring improve outcomes.

Quick Overview

This guide is for educational purposes. Always consult your veterinarian for diagnosis and treatment.


Pathophysiology (Explained Simply)

Cats are efficient at storing fat. When an obese cat stops eating, the body mobilizes fat stores to supply energy. Cats rely heavily on hepatic pathways to process fatty acids; when the influx overwhelms hepatic capacity, triglycerides accumulate inside hepatocytes (fatty change). This leads to impaired bile flow (cholestasis), decreased liver function (metabolism, clotting factor production, detoxification) and clinical signs such as jaundice, vomiting and lethargy.

Key risk factor: obesity plus short‑term anorexia (often 3–7 days) is enough to trigger the cascade.


Breed‑specific Risk Factors and Prevalence


Clinical Signs and Stages

Typical signs develop over days to weeks and include:

There is no formal universal staging system, but clinically you will see a progression from early anorexia and weight loss to jaundice, stupor and coagulopathy in severe, untreated cases.


Diagnostic Approach

  • History and physical exam
  • - Recent anorexia, weight status, concurrent illness, medications, or stressors.

  • Baseline tests
  • - CBC, serum biochemistry (ALT, AST, ALP, GGT, bilirubin), electrolytes, glucose, BUN/creatinine. - Expect marked hyperbilirubinemia, variable elevations in hepatocellular enzymes and cholestatic enzymes.

  • Specific liver testing
  • - Serum bile acids (pre/postprandial) for hepatic function. - Coagulation profile (PT/PTT) because coagulopathy may affect biopsy decisions; consider vitamin K if PT prolonged.

  • Imaging
  • - Abdominal ultrasound: enlarged, hyperechoic liver typical of fatty infiltration; rule out biliary obstruction and other intra‑abdominal disease.

  • Cytology/biopsy
  • - Fine‑needle aspirate or ultrasound‑guided biopsy can confirm fatty change and rule out other hepatic diseases. Biopsy is not required if the clinical picture is classic and patient is too unstable for anesthesia.

  • Additional tests
  • - Rule out other causes of anorexia and hepatic disease (toxins, pancreatitis, inflammatory disease, hepatic lipidosis secondary to underlying illness). Infectious testing (FeLV/FIV) as appropriate.

    When to refer: severe cases (marked coagulopathy, uncertain diagnosis, need for anesthesia for biopsy or surgical intervention) benefit from referral to a specialist in internal medicine or a tertiary hospital.


    Treatment: Immediate Priorities

    Goals: reverse anorexia quickly, correct dehydration and electrolyte abnormalities, support hepatic function, prevent and treat complications.

  • Stabilization
  • - IV fluids to correct dehydration and restore perfusion (e.g., Lactated Ringer’s). Monitor electrolytes and glucose closely. - Correct hypoglycemia if present (dextrose bolus/CRI may be needed). - Replace potassium, magnesium and phosphate as indicated. Monitor for refeeding hypophosphatemia (see below). - Antiemetics to control vomiting (maropitant 1 mg/kg SC/PO q24h; ondansetron 0.1–0.2 mg/kg IV/IM q8–12h may be used).

  • Nutritional support — the single most important therapy
  • - Aggressive, early enteral nutrition is necessary. Cats must be fed—force‑feeding by syringe is often unsuccessful and risky. Enteral tube feeding is standard. - Tube choices: - Esophagostomy tube (E‑tube): preferred for medium‑ to long‑term nutrition (weeks). Can be placed under brief general anesthesia; allows full meals and medication administration. - Nasoesophageal/nasogastric tube: easier to place awake but suitable only for short‑term feeding and smaller volumes. - Gastrostomy tube: considered for prolonged long‑term needs or if esophagostomy contraindicated.

    - Practical points about the esophagostomy tube: - Placement performed by a veterinarian under sedation/general anesthesia. - Complications: local infection, tube dislodgement, aspiration if incorrectly placed, transient cough. - Home care: flush with warm water before/after use, keep exit site clean, protect the site, and monitor for swelling/erythema.

  • Feeding protocol and refeeding
  • - Begin with conservative calories to reduce refeeding risk: start at ~25–33% of resting energy requirement (RER) on day 1, then increase gradually over 3–5 days toward full needs. - RER is commonly estimated as 70 × (body weight in kg)^0.75 or the simpler 30 × body weight (kg) + 70 for adult cats — clarify with your veterinarian which formula they use. Example: a 5 kg cat RER ≈ 200–250 kcal/day; start ~50–80 kcal on day 1. - Typical target: achieve 100% of RER within 3–5 days and then increase to meet recovery needs (often 1.2–1.5 × RER). - Use calorie‑dense, palatable, high‑protein veterinary recovery diets formulated for cats (Hill’s a/d, Royal Canin Recovery, Purina EN Recovery). Although hepatic disease sometimes suggests protein restriction, hepatic lipidosis patients need adequate high‑quality protein to restore hepatic function.

  • Drugs and hepatoprotectants
  • - SAMe (S‑adenosylmethionine, e.g., Denosyl): commonly given as hepatoprotectant; typical dose ~20 mg/kg PO once daily (follow product and vet guidance). - Ursodeoxycholic acid: 10–15 mg/kg PO divided q24h–q12h to improve bile flow (use with caution if obstruction suspected). Discuss with your vet. - Vitamin K1 (phytonadione): 1–2 mg/kg SC or PO q12–24h if PT prolonged or bleeding risk. - Appetite stimulants: Mirataz (mirtazapine transdermal ointment) 2 mg/cat once daily is FDA‑approved for cats. Oral mirtazapine may be used off‑label; typical dosing varies (e.g., 1.88–3.75 mg every 48–72 hours in some protocols). Use only under your vet’s guidance. - Antibiotics are not routinely indicated unless concurrent infection is suspected.

  • Monitoring during hospitalization
  • - Daily weight, intake records, and attitude/appetite. - Twice‑daily glucose checks early if receiving dextrose or at high risk for hypoglycemia. - Daily or every‑other‑day bloodwork: electrolytes, phosphorus, ALT/AST, bilirubin, and glucose. Recheck coagulation if abnormal initially. - Watch for refeeding syndrome — hypophosphatemia is the most important electrolyte disturbance and needs prompt correction (phosphate supplementation orally or IV as needed).


    Long‑term Management and Monitoring


    Complications to Watch For


    Prognosis and Quality of Life


    Living With Hepatic Lipidosis: Practical Daily Tips


    Prevention


    When to See Your Vet Urgently

    Seek immediate veterinary attention if your cat:


    This guide is for educational purposes. Always consult your veterinarian for diagnosis and treatment.

    Selected References and Resources

    (Primary source: MSD Veterinary Manual — https://www.msdvetmanual.com/)

    Frequently Asked Questions

    How soon will my cat improve after starting tube feeding?

    Clinical improvement (activity and vomiting control) is often seen within 48–72 hours once adequate calories and fluids are provided. Jaundice and liver enzyme normalization can take days to weeks; full recovery commonly requires several weeks of support.

    Is the esophagostomy tube painful and will my cat tolerate it at home?

    Tube placement is performed under sedation or general anesthesia; afterward most cats tolerate the tube well if pain and nausea are controlled. Owners typically manage home tube feeding after instruction; common issues are minor and manageable (cleaning, bandage care).

    Can I feed my cat a low‑protein diet because of the liver disease?

    No. In hepatic lipidosis, cats are protein‑depleted and need high‑quality protein to recover. Prescription recovery diets formulated for feline hepatic support are usually recommended. Protein restriction is more relevant in certain chronic hepatic encephalopathy cases, not acute hepatic lipidosis.

    What are the signs of refeeding syndrome I should watch for?

    Watch for weakness, tremors, increased respiratory effort, seizures, or sudden worsening of clinical condition. These can signal hypophosphatemia or other electrolyte shifts; immediate veterinary evaluation and bloodwork are required.

    References & Citations

    Parts of this article reference data from MSD Veterinary Manual.

    Tags: felinehepatic-lipidosisnutritionesophagostomy-tube